Filing Flows › Comparisons › PHAT vs SNDX
Phathom Pharmaceuticals vs Syndax Pharmaceuticals: PHAT and SNDX compared
Phathom Pharmaceuticals is the larger company: $84.7M of revenue in its latest quarter (Q3 2026) against $83.3M for Syndax Pharmaceuticals (Q3 2026). Syndax Pharmaceuticals is growing faster (+82% against +71% a year earlier). Phathom Pharmaceuticals is more profitable, with an operating margin of -0.1% against -50.3%.
Where the money goes: PHAT and SNDX
Phathom Pharmaceuticals (PHAT) · Q3 2026
Phathom Pharmaceuticals, Q3 2026: revenue $84.7M (+71% year over year), operating margin -0.1%, net loss $13.9M, operating cash flow $1.8M. The chart follows the revenue to costs, profit and cash.
Syndax Pharmaceuticals (SNDX) · Q3 2026
Syndax Pharmaceuticals, Q3 2026: revenue $83.3M (+82% year over year), operating margin -50.3%, net loss $49.4M, operating cash flow −$27.3M. The chart follows the revenue to costs, profit and cash.
| Phathom Pharmaceuticals (PHAT) | Syndax Pharmaceuticals (SNDX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $84.7M | $83.3M |
| Revenue growth, Y/Y | +71% | +82% |
| Operating margin | -0.1% | -50.3% |
| Net earnings | −$13.9M | −$49.4M |
| Net margin | -16.4% | -59.3% |
| Operating cash flow | $1.8M | −$27.3M |
| Free cash flow | $1.7M | — |
| Market value | — | $1.3B |
| Analysts’ mean target | — | $35.45 |
Where the revenue comes from
Syndax Pharmaceuticals
- Product: $60.7M (73%)
- Collaboration Revenue: $22.6M (27%)
Questions
Which is bigger, Phathom Pharmaceuticals or Syndax Pharmaceuticals?
Phathom Pharmaceuticals is the larger company: $84.7M of revenue in its latest quarter (Q3 2026) against $83.3M for Syndax Pharmaceuticals (Q3 2026).
Is Phathom Pharmaceuticals or Syndax Pharmaceuticals growing faster?
Syndax Pharmaceuticals is growing faster (+82% against +71% a year earlier).
Which is more profitable, Phathom Pharmaceuticals or Syndax Pharmaceuticals?
Phathom Pharmaceuticals is more profitable, with an operating margin of -0.1% against -50.3%.
More: Phathom Pharmaceuticals earnings · how Phathom Pharmaceuticals makes money · Syndax Pharmaceuticals earnings · how Syndax Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.